Wednesday, 25 November 2020

MCQ-181

 



Answer: a) Drotrecogin alfa

Drotrecogin alfa does not improve mortality in severe sepsis or septic shock but increases the bleeding risks, because of being anti-inflammatory, profibrinolytic and anti-thrombotic properties.


No comments:

Post a Comment